Article
FCRL1 immunoregulation in B cell development and malignancy
25 Sept 2023
Abstract excerpt
Immunotherapeutic targeting of surface regulatory proteins and pharmacologic inhibition of critical signaling pathways has dramatically shifted our approach to the care of individuals with B cell malignancies. This evolution in therapy reflects the central role of the B cell receptor (BCR) signaling complex and its co-receptors in the pathogenesis of B lineage leukemias and lymphomas. Members of the Fc...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
